Analysis of postprogression survival of patients with advanced hepatocellular carcinoma treated with sorafenib

被引:0
|
作者
Wada, Y. [1 ]
Takami, Y. [1 ]
Matsushima, H. [1 ]
Ryu, T. [1 ]
Mikagi, K. [1 ]
Saitsu, H. [1 ]
机构
[1] Natl Hosp Org, Kyushu Med Ctr, Clin Res Inst, Dept Hepatobiliary Pancreat Surg, Fukuoka, Japan
关键词
D O I
10.1016/S0168-8278(17)31709-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-103
引用
下载
收藏
页码:S630 / S631
页数:2
相关论文
共 50 条
  • [1] Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib Treatment
    Kuzuya, Teiji
    Ishigami, Masatoshi
    Ishizu, Yoji
    Honda, Takashi
    Hayashi, Kazuhiko
    Ishikawa, Tetsuya
    Nakano, Isao
    Hirooka, Yoshiki
    Goto, Hidemi
    ONCOLOGY, 2018, 95 (02) : 91 - 99
  • [2] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with Sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Biondetti, P.
    Pellicelli, A. M.
    Sangiovanni, A.
    Lampertico, P.
    Marignani, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S207 - S208
  • [3] Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib
    Otsuka, Taiga
    Eguchi, Yuichiro
    Kawazoe, Seiji
    Yanagita, Kimihiko
    Ario, Keisuke
    Kitahara, Kenji
    Kawasoe, Hiroaki
    Kato, Hiroyuki
    Mizuta, Toshihiko
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 879 - 886
  • [4] Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Antonelli, G.
    Gigante, E.
    Iavarone, M.
    Begini, P.
    Sangiovanni, A.
    Iannicelli, E.
    Biondetti, P.
    Pellicelli, A. M.
    Miglioresi, L.
    Marchetti, P.
    Lampertico, P.
    Marignani, M.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 14 - 14
  • [5] Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: An Analysis of SEER-Medicare Database
    Parikh, Neehar D.
    Marshall, Vincent D.
    Nathan, Hari
    Balkrishnan, Rajesh
    Shahinian, Vahakn
    HEPATOLOGY, 2015, 62 : 409A - 410A
  • [6] Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma
    Peixoto, Renata D'Alpino
    Renouf, Daniel J.
    Gill, Sharlene
    Cheung, Winson Y.
    Lim, Howard J.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (04) : 259 - 264
  • [7] Impact of statin on the survival of patients with advanced hepatocellular carcinoma treated with sorafenib or lenvatinib
    Cho, Hyo Jung
    Han, Ji Eun
    Cheong, Jae Youn
    Kim, Soon Sun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S572 - S572
  • [8] The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
    Han, Ji Eun
    Kim, Jisu
    Cheong, Jae Youn
    Kim, Soon Sun
    Lim, Sun Gyo
    Yang, Min Jae
    Noh, Choong-Kyun
    Lee, Gil Ho
    Eun, Jung Woo
    Park, Bumhee
    Cho, Hyo Jung
    CANCERS, 2024, 16 (02)
  • [9] IMPACT OF SARCOPENIA ON SURVIVAL OF PATIENTS AFFECTED BY ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
    Reggidori, N.
    Lani, L.
    Renzulli, M.
    Gramenzi, A.
    Iannone, G.
    Granito, A.
    Piscaglia, F.
    Golfieri, R.
    Trevisani, F.
    Biselli, M.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S151 - S151
  • [10] The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
    Caputo, Francesco
    Dadduzio, Vincenzo
    Tovoli, Francesco
    Bertolini, Giulia
    Cabibbo, Giuseppe
    Cerma, Krisida
    Vivaldi, Caterina
    Faloppi, Luca
    Rizzato, Mario Domenico
    Piscaglia, Fabio
    Celsa, Ciro
    Fornaro, Lorenzo
    Marisi, Giorgia
    Conti, Fabio
    Silvestris, Nicola
    Silletta, Marianna
    Lonardi, Sara
    Granito, Alessandro
    Stornello, Caterina
    Massa, Valentina
    Astara, Giorgio
    Delcuratolo, Sabina
    Cascinu, Stefano
    Scartozzi, Mario
    Casadei-Gardini, Andrea
    PLOS ONE, 2020, 15 (05):